Skip to content
etf.net

Launched · SEC filings

First Trust Health Care AlphaDEX Fund

FXHNYSE ArcaFirst TrustB

$137.67+0.23 (+0.17%)

At close: Nov 2, 2026, 4:00 PM ET

B58/ 100

Rank 10 of 25 in Health Care (Broad)

B58/100Rank 10 of 25inHealth Care (Broad)
Intraday session: up, 79 prints from 137.44 to 137.67. Range 137.03 to 138.04. Use the arrow keys to read each point.137.00137.20137.80138.0010 AM12 PM2 PM4 PM
Expense ratio
0.61%
Fund size
$1.16B
1Y total return
+24.1%
Yield · Last 12 months
0.54%
Holdings
73
Avg volume · 30D
56.5K sh
52W range
low $104.53high $139.55
Launched
Filings
SEC EDGAR

The ETF.net FXH Grade

Based on 5 of 6 pillars

B

Score 58 out of 100

Category
Health Care (Broad)⁠
Rank
10 of 25
Six-pillar profile for FXH. Scores out of 100: Cost 33, Risk 70, Mission not scored, Tradability 78, Holdings 82, Durability 67. Strongest: Holdings (82). Weakest: Cost (33). Based on 5 of 6 pillars.

Score 58 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    D33 out of 100
    Rank 17 of 25

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A70 out of 100
    Rank 9 of 25

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    A78 out of 100
    Rank 6 of 25

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A82 out of 100
    Rank 5 of 25

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    B67 out of 100
    Rank 11 of 25

Our read on FXH

ETF.net Research

In short

BA 2007-vintage twist on health care: instead of owning the whole sector, FXH runs Russell 1000 health care names through First Trust's AlphaDEX growth-and-value screen and holds roughly 80 of them.

Stated mandate

The fund seeks before-fee results generally corresponding to the price and yield of the StrataQuant® Health Care Index. That index uses the AlphaDEX® methodology to select and weight health care stocks from the Russell 1000® Index.

Why people hold it

  • AlphaDEX selects and weights health care stocks from the Russell 1000 using growth and value marks. A published rules screen, not a manager's hunch.ftportfolios.com
  • Live since 2007 and now a multi-billion-dollar fund. This is a long-running strategy with a real record, not a recent launch chasing a theme.
  • A focused book of about 80 stocks, so the screen's picks actually show up in results rather than getting diluted across the full sector. Pays quarterly.

Worth knowing

  • The 0.61% fee runs near double the typical multifactor fund's. Cheap core peers like IUSG and VONV charge a small fraction of it.
  • Thinly traded for its size, so spreads can widen and fills on a market order may land away from the fund's underlying value.
  • Fee load and volatility profile leave it in the bottom quartile of its multifactor peer group, a group topped by broad, low-cost core funds.

FXH Holdings

Holdings pillarA82 out of 100Rank 5 of 25 in Health Care (Broad)
Asset class
Stocks
Holdings
73
Top-10 weight
24%
Largest holding
HALO2.7%

Sectors

  • Health Care99.5%
  • Technology0.5%

Geography

  • United States100.00%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueHeld by ETFs
1HALOHalozyme Therapeutics, Inc.2.68%237,890$31.1M219
2CAICaris Life Sciences, Inc.2.54%857,433$29.4M103
3CNCCentene Corporation2.49%422,780$28.9M335
4CIThe Cigna Group2.48%96,615$28.8M365
5ZBHZimmer Biomet Holdings, Inc.2.41%295,660$27.9M249
6MEDPMedpace Holdings, Inc.2.36%42,076$27.4M217
7GMEDGlobus Medical, Inc. (Class A)2.36%350,643$27.4M160
8UHSUniversal Health Services, Inc. (Class B)2.29%150,712$26.5M237
9GHGuardant Health, Inc.2.27%147,250$26.3M183
10NTRANatera, Inc.2.27%63,544$26.3M239
11LLYEli Lilly and Company2.22%18,161$25.7M593
12REGNRegeneron Pharmaceuticals, Inc.2.22%27,708$25.7M422
13DXCMDexCom, Inc.2.16%304,360$25M375
14EXELExelixis, Inc.2.15%359,712$25M251
15GEHCGE HealthCare Technologies Inc.2.12%321,409$24.6M308

Showing 1–15 of 73 holdings

FXH Performance

Launched May 8, 2007

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

FXH$12,407
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. FXH $12,407. SPY $11,199. Use the arrow keys to read each point.$10,000$11,000$12,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for FXH. Periods over one year show the average yearly return.
PeriodFXH
Year to date+21.3%
1 month+5.1%
3 months+8.4%
1 year+24.1%
3 yearsper year+15.6%
5 yearsper year+3.0%
10 yearsper year+9.7%

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for FXH
YearReturn barFXH
2026 YTD+21.3%
2025+10.2%
2024+1.0%
2023−4.5%
2022−12.2%

FXH in the news

FXH Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
0.54%Last 12 months
Payout per share
$0.74Last 12 months
Last payment
$0.29 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 17 payments from 2017 to 2026 YTD. Sep 23, 2022 $0.10; Dec 23, 2022 $0.12; Mar 24, 2023 $0.04; Jun 27, 2023 $0.04; Sep 22, 2023 $0.03; Dec 22, 2023 $0.13; Mar 21, 2024 $0.11; Jun 27, 2024 $0.11; Sep 26, 2024 $0.13; Dec 13, 2024 $0.09; Mar 27, 2025 $0.07; Jun 26, 2025 $0.06; Sep 25, 2025 $0.58; Dec 12, 2025 $0.14; Mar 26, 2026 $0.19; Jun 25, 2026 $0.12; Sep 24, 2026 $0.29. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 24, 2026Sep 30, 2026$0.29
Jun 25, 2026Jun 30, 2026$0.12
Mar 26, 2026Mar 31, 2026$0.19
Dec 12, 2025Dec 31, 2025$0.14
Sep 25, 2025Sep 30, 2025$0.58
Jun 26, 2025Jun 30, 2025$0.06
Mar 27, 2025Mar 31, 2025$0.07
Dec 13, 2024Dec 31, 2024$0.09
Sep 26, 2024Sep 30, 2024$0.13
Jun 27, 2024Jun 28, 2024$0.11
Mar 21, 2024Mar 28, 2024$0.11
Dec 22, 2023Dec 29, 2023$0.13

See all 22 payments⁠

$10,000 in FXH 10 years ago paid $426 in dividends.⁠

FXH Risk

Risk pillarA70 out of 100Rank 9 of 25 in Health Care (Broad)
How much the fund’s monthly returns vary, scaled to a year.
14.3%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.78
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−27.6%
Trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.72
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

FXH Cost

Compare FXH and XLV

Overpaying vs XLV, cheapest in Health Care (Broad)

$10,309

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • FXH 0.61%

    $11,998

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • FXH 0.61%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2.5K$5K$7.5K$10K$12.5K051015202530FXH $11,998XLV $1,689

Year by year

YearFXHXLVOverpaying
10$1,093$147$946
20$4,181$575$3,606
30$11,998$1,689$10,309

Other funds in Health Care (Broad)

See others